MDM2-IN-1

  • CAT Number: I017376
  • CAS Number: 1410737-09-5
  • Molecular Formula: C₂₃H₂₁Cl₂FN₂O₃
  • Molecular Weight: 463.33
  • Purity: ≥95%
Inquiry Now

MDM2-IN-1 (Cat No.:I017376) is a small molecule inhibitor of the MDM2-p53 interaction, which is a key regulator of cell cycle progression and apoptosis. By inhibiting this interaction, MDM2-IN-1 can stabilize and activate p53, resulting in the induction of cell cycle arrest and apoptosis in cancer cells. MDM2-IN-1 has demonstrated potent antitumor activity in various cancer cell lines and animal models and is being investigated as a potential cancer therapeutic agent.

Catalog Number I017376
CAS Number 1410737-09-5
Molecular Formula

C₂₃H₂₁Cl₂FN₂O₃

Purity 95%
Storage 4°C, protect from light
InChI InChI=1S/C23H21Cl2FN2O3/c24-12-7-8-14-16(11-12)27-21(31)23(14)17(13-5-4-6-15(25)18(13)26)19(20(29)30)28-22(23)9-2-1-3-10-22/h4-8,11,17,19,28H,1-3,9-10H2,(H,27,31)(H,29,30)/t17-,19+,23+/m0/s1
InChIKey GQQZEPFAYBPYQU-GEQKSPFYSA-N
SMILES C1CCC2(CC1)C3(C(C(N2)C(=O)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC3=O
Reference

[1]. Aguilar A, et al. Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles. J Med Chem. 2014 Dec 26;57(24):10486-98.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!